Improving Patient Understanding of the Language of Precision Medicine
Release Date: 06/20/2023
The JADPRO Podcast
Steven H. Wei, EdD, MPH, MS, PA-C, DFAAPA, Advanced Practice Provider Supervisor at MD Anderson Cancer Center, discusses the impact of a positive team culture on well-being. With years of expertise in both clinical practice and research, Dr. Wei guides us through his research, unveiling the nuanced ways in which psychological safety impacts the daily lives, resilience, and overall well-being of advanced practitioners. Related Content: by Edgar Schein by Amy Edmondson
info_outlineThe JADPRO Podcast
Get some tips for preparing for your trip to JADPRO Live, happening in Orlando from November 9-12, 2023. JADPRO Live is an annual educational conference for advanced practitioners in heme/onc, including nurse practitioners, physician assistants, pharmacists, and other advanced practice nurses. Related content: Download the Blinq digital business card JADPRO Live The Elevator Pitch: Communicating Your Expertise, Experience, and Value to Patients, Co-Workers, and Prospective Employers in an Instant. J Adv Pract Oncol 2021;12(3):250–252.
info_outlineThe JADPRO Podcast
Ly Dsouza, PA-C, MPAS, a physician assistant in clinical research in the Lymphoma/Myeloma Department at MD Anderson Cancer Center in Houston, describes the hybrid role of a research advanced practice provider (APP). This unique role combines the responsibilities of a study coordinator and provider, capitalizing on the APP's clinical knowledge and close management of toxicities to guide the patient through a CAR T-cell clinical trial. Related Content: The Role of the Research Advanced Practice Provider in CAR T-Cell Clinical Trials. J Adv Pract Oncol 2023;14(1):54–66. APSHO on CRS and...
info_outlineThe JADPRO Podcast
Jibran Majeed, DNP, ACNP-BC, CCRN, of Memorial Sloan Kettering Cancer Center, details how his team created a clinical decision tool to help with decision making for patients who present with new venous thromboembolism. Related Content
info_outlineThe JADPRO Podcast
Gastrointestinal stromal tumors (GISTs) are considered rare, yet they represent the most common sarcomas of the gastrointestinal tract. Sandra Brackert, NP, of UCLA Sarcoma Center, and Kathleen Polson, NP, of Dana-Farber Cancer Institute, speak with host Wendy Vogel, MSN, FNP, AOCNP®, on the effective management of patients with GIST who have progressed on multiple therapies. Related Content: Management of Patients With Advanced Gastrointestinal Stromal Tumor: Emphasis on Fourth-Line Treatment With Ripretinib. J Adv Pract Oncol...
info_outlineThe JADPRO Podcast
Many communication skills that advanced practice providers (APP) develop are similar to those of other providers. However, a survey reveals unique communication challenges for APPs that stem from public lack of understanding of this unique role on the multidisciplinary care team. Related Content: General and Unique Communication Skills Challenges for Advanced Practice Providers: A Mixed-Methods Study. Episode 41: The Never-Ending Need to Explain Yourself: Defining Your AP Role. Comskil: Communication Skills Training Program & Research Laboratory.
info_outlineThe JADPRO Podcast
Feeling like your tank is empty? You may be coping with change fatigue. Katherine Albert, DNP, FNP-BC, AOCNP, of University of Colorado at Colorado Springs, speaks to host Wendy Vogel, MSN, FNP, AOCNP, about how the pandemic has depleted our reserves and left us unprepared to deal with rapid changes in health care. Katherine and Wendy discuss strategies to refuel your tank, including early communication, team cohesion, and taking time to rest, reflect, and recover. Related Content: Change Management Leading change: Why transformation efforts fail Healthcare Leadership Lab Change Fatigue The...
info_outlineThe JADPRO Podcast
Teams do their best work when they feel connected. Ginger Johnson, speaker and author, talks with host Wendy Vogel, MSN, FNP, AOCNP®, on the power of connection to align values and encourage new ideas and growth within health-care teams. Related Content: Use code CANON5 for $5 off
info_outlineThe JADPRO Podcast
Health-care disparities create barriers to disease prevention, early detection, and treatments. These disparities are found across all cancer types. In this episode, Rose DiMarco, PharmD, BCPS, BCOP, Thomas Jefferson University Hospitals, and Joseen Chundamala, PharmD, University of Pennsylvania Health System, discuss actionable steps oncology advanced practitioners can incorporate into their everyday practice to consistently provide high-quality care to all patients. Related Content: (APSHO members only)
info_outlineThe JADPRO Podcast
Adverse childhood experiences, or ACEs, are potentially traumatic events that occur in childhood. Having multiple ACEs is a major risk factor for many health conditions, including cancer. Host Wendy H. Vogel, MSN, FNP, AOCNP®, talks with Sharon Moore, DPh, Regional Coordinator for ONE Tennessee and Public Health Academic Detailer for Metro Drug Coalition, on how being cognizant of potential ACEs a patient with cancer may have can help inform and improve the care and education advanced practitioners provide. Related Content:
info_outlineGenomic or biomarker testing? Germline or genetic testing? The various terms that providers use about testing can cause confusion and lead to suboptimal testing and care.
Nikki Martin, MA, Director of Precision Medicine Initiatives at LUNGevity Foundation, talks about the work of the Consistent Testing Terminology Working Group to encourage the use of consistent, plain language terms for biomarker and genetic testing that are applicable across cancer types. Allyson Price, MPAS, PA-C, a member of the working group, describes the important role of the advanced practitioner in explaining testing results to patients.
The official recommendations are: “Biomarker testing” is the preferred term for tests that identify characteristics, targetable findings, or other test results originating from malignant tissue. “Genetic testing for an inherited mutation” or “genetic testing for inherited cancer risk” are recommended to describe tests to identify germline mutation.
Resources: